Filing Details

Accession Number:
0001179110-18-012211
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-10-16 18:46:29
Reporting Period:
2018-10-12
Accepted Time:
2018-10-16 18:46:29
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1034842 Rigel Pharmaceuticals Inc RIGL Pharmaceutical Preparations (2834) 943248524
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1725908 Nelson Cabatuan Rigel Pharmaceuticals, Inc.
1180 Veterans Blvd.
South San Francisco CA 94080
Principal Accounting Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-10-12 10,000 $3.12 58 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 5, 2018.
  2. Includes Reporting Person's purchases of 5,000 shares on December 29, 2017 and 5,000 shares on June 26, 2018 under the Issuer's Employee Stock Purchase Plan.